Ioana N Draghici

  • Citations Per Year
Learn More
PURPOSE The combination of Gemcitabine (GEM)/carboplatin (CBDCA) has demonstrated activity in the treatment of stage III and IV non-small-cell lung cancer (NSCLC). This phase III randomized trial compared the response rate, survival rate, and toxicity of the combination of GEM plus CBDCA with the combination of VLB plus CDDP. METHODS Chemonaïve patients(More)
  • 1